Radnet (RDNT) closed at $76.89 on November 16, 2026, up 0.6% from the previous close, on volume of 484,100 shares (30-day average 627,401).
Data as of November 16, 2026.
16-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 5, 2026 | Put Spread | 18-Dec-2660 : 75 P | 818 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the largest for 5, 30, 60 and 90 days
Analysts Offer Insights on Healthcare Companies: Radnet (RDNT) and Roche Holding AG (OtherRHHVF)
TipRanks (Tue, 17-Nov 3:10 AM ET)
RadNet Earnings Call Highlights Record Growth and AI Momentum
TipRanks (Sun, 15-Nov 7:10 PM ET)
Globe Newswire (Sun, 8-Nov 4:01 PM ET)
RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference Call
Globe Newswire (Thu, 29-Oct 6:00 AM ET)
RadNet, Inc. Announces Agreement to Acquire ONRAD, Inc.
Globe Newswire (Mon, 26-Oct 4:01 PM ET)
New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies
Globe Newswire (Thu, 8-Oct 6:00 AM ET)
Globe Newswire (Thu, 1-Oct 6:00 AM ET)
Globe Newswire (Wed, 9-Sep 6:00 AM ET)
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
Globe Newswire (Wed, 9-Sep 6:00 AM ET)
Globe Newswire (Tue, 8-Sep 6:00 AM ET)
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
Radnet trades on the NASDAQ stock market under the symbol RDNT.
As of November 16, 2026, RDNT stock price climbed to $76.89 with 484,100 million shares trading.
RDNT has a beta of 0.79, meaning it tends to be less sensitive to market movements. RDNT has a correlation of 0.06 to the broad based SPY ETF.
RDNT has a market cap of $6.06 billion. This is considered a Mid Cap stock.
Last quarter Radnet reported $638 million in Revenue and $.30 earnings per share. This fell short of revenue expectation by $-620,736 and exceeded earnings estimates by $.08.
In the last 3 years, RDNT traded as high as $93.65 and as low as $30.27.
The top ETF exchange traded funds that RDNT belongs to (by Net Assets): IJR, VTI, IWM, VB, QTUM.
RDNT has underperformed the market in the last year with a return of +4.7%, while SPY returned +11.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RDNT shares. However, RDNT has outperformed the market in the last 3 month and 2 week periods, returning -0.5% and +4.6%, while SPY returned -4.6% and -2.1%, respectively. This indicates RDNT has been having a stronger performance recently.
RDNT support price is $74.40 and resistance is $78.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RDNT shares will trade within this expected range on the day.